No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study.

Guri HagbergHege Ihle-HansenBrynjar FureBente ThommessenHåkon Ihle-HansenAnne Rita ØksengårdMona K BeyerTorgeir B WyllerEbba Gløersen MüllerSarah T PendleburyPer Selnes

Published in: BMC neurology (2020)

Clinicaltrials.gov (NCT00506818). July 23, 2007. Inclusion from February 2007, randomization and intervention from May 2007 and trial registration in July 2007.

Keyphrases

randomized controlled trial
study protocol
phase iii
clinical trial
phase ii
open label